| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/17/1994 | WO1994003445A1 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists |
| 02/17/1994 | WO1994003431A1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/17/1994 | WO1994003188A1 Ibuprofen-antacid combinations |
| 02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/17/1994 | CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | CA2141051A1 Substituted nitrogen-containing heterocycles |
| 02/17/1994 | CA2140917A1 Ibuprofen-antacid combinations |
| 02/17/1994 | CA2139854A1 Peptidyl 4-amino-2, 2-difluoro-3-oxo-1, 6-hexanedioic acid derivatives as antiinflammatory agents |
| 02/17/1994 | CA2134565A1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/16/1994 | EP0582916A1 N-methansulfonyl-2-(3-isobutyl-3-(quinol-2-yl-methoxy)-phenyl)-2-cycloalkylacetamides, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0582908A1 2-Substituted guinolylmethoxy-phenylacetic acid derivatives, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0409931B1 Quinuclidine therapeutic agents |
| 02/16/1994 | CN1082046A 9-Amino-pyridazino |4',5':3,4¨ pyrrolo-|2,1-1¨ isochinoline and its application in preparation of pharmaceutic |
| 02/16/1994 | CN1082027A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/15/1994 | US5286858 Optically active thienotriazolodiazepine compounds |
| 02/15/1994 | US5286847 Replacing the arginine residue with glycine at position 11 of the mature form; reduced bioactivity without loss of receptor binding affinity |
| 02/15/1994 | US5286716 Inhibitor of the proliferation of endothelial cells |
| 02/15/1994 | CA1327050C Phenolic thioethers, sulfoxides, and disulfides as inhibitors of 5-lipoxygenase |
| 02/15/1994 | CA1327011C Pharmaceutical compositions for piperidino alkanol-ibuprofen combination |
| 02/15/1994 | CA1327009C Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative |
| 02/15/1994 | CA1326999C Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function |
| 02/13/1994 | CA2103600A1 Isobutyl-substituted methanesulphonyl- quinolyl-methoxyphenyl-cycloalkylacetamides |
| 02/12/1994 | CA2103521A1 Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
| 02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
| 02/09/1994 | EP0581954A1 USE OF -g(a)-HYDROXYKETOALKYL DERIVATIVES AS PROTECTIVE LIGHT FILTERS. |
| 02/09/1994 | EP0581916A1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
| 02/09/1994 | EP0581777A1 Stereoselective preparation of substituted piperidines |
| 02/08/1994 | US5284873 Treatment of benign hypertrophy of the prostate |
| 02/08/1994 | US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer |
| 02/08/1994 | US5284645 Stable, biocompatible |
| 02/08/1994 | CA1326940C Purification of lfa-3 |
| 02/08/1994 | CA1326853C Ethynylheteroaromatic acids having retinoic acid-like activity |
| 02/03/1994 | WO1994002595A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | WO1994002498A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | WO1994002465A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
| 02/03/1994 | WO1994002461A1 Azacyclic compounds |
| 02/03/1994 | WO1994002459A1 Indolinyl n-hydrozyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
| 02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression |
| 02/03/1994 | WO1994002175A1 Alleviation of symptoms associated with inflammatory disease states |
| 02/03/1994 | WO1994002162A1 Peptide medicaments for treating disease |
| 02/03/1994 | WO1994002152A2 Phosphono derivatives as antiinflammatory and antiarthritic agents |
| 02/03/1994 | WO1994002148A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | WO1994002107A2 Method and medicament for inhibiting neutrophil elastase and cathepsin g |
| 02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression |
| 02/03/1994 | CA2140630A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | CA2140343A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | CA2140033A1 Peptide medicaments for treating disease |
| 02/03/1994 | CA2138650A1 Azacyclic compounds |
| 02/02/1994 | EP0581282A1 Use of lipid-bound glycosaminoglyrans for the treatment of rheumatoid arthritis |
| 02/02/1994 | EP0580763A1 Compositions and methods for endothelial binding |
| 02/02/1994 | EP0580658A1 Nabumetone powders |
| 02/02/1994 | EP0580650A1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof |
| 02/02/1994 | EP0580633A1 Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract |
| 02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
| 02/02/1994 | EP0580594A1 New inhibitors of endothelial cell proliferation |
| 02/02/1994 | EP0363491B1 Bacterial preparation for prophylaxis and treatment of inflammatory processes and allergic diseases |
| 02/02/1994 | CN1023646C Saccharide derivatives of protocatechualdehyde and the prepn. method |
| 02/01/1994 | US5283361 N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors |
| 02/01/1994 | US5283268 Compounds for the treatment of inflammation and allergy |
| 02/01/1994 | US5283245 Antiinflammatory agent, antiallergens |
| 02/01/1994 | US5283243 Anti-inflammatory, anti-allergic, hypotensive and vasodilating agents |
| 01/31/1994 | CA2101482A1 Antirheumatic composition |
| 01/31/1994 | CA2100600A1 New carbohydrate-based anti-inflammatory agents |
| 01/29/1994 | CA2101350A1 Peptides derived from trifluoromethylketones, a process for their preparation and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580502A1 3-(Hydroxybenzylidenyl)-indoline-2-ones and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580378A1 Substituted benzoate derivatives |
| 01/26/1994 | EP0579827A1 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
| 01/26/1994 | EP0579769A1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
| 01/26/1994 | EP0579739A1 Interleukin-8 receptors and related molecules and methods |
| 01/26/1994 | EP0579731A1 Disubstituted naphthalenes |
| 01/26/1994 | EP0579648A1 Thiol-carboxylic acid derivatives as collagenase inhibitors |
| 01/25/1994 | US5281722 Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
| 01/25/1994 | US5281623 Method for treating inflammation |
| 01/25/1994 | US5281588 Treatment of trypanosomia parasites |
| 01/25/1994 | US5281420 Solid dispersion compositions of tebufelone |
| 01/25/1994 | CA1326448C Steroid ointment formulation |
| 01/25/1994 | CA1326447C Steroid cream formulation |
| 01/24/1994 | CA2100640A1 Substitute benzoate derivatives |
| 01/22/1994 | CA2100944A1 3-(hydroxybenzylidenyl)-indoline-2-ones, their preparation and the pharmaceutical compositions containing them |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001455A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | WO1994001430A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 01/20/1994 | WO1994001429A1 (3r,4r)-δ6-tetrahydrocannabinol-7-oic acids |
| 01/20/1994 | WO1994001406A1 Contrast agents for mr diagnosis |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001127A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | CA2140140A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | CA2140034A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 01/20/1994 | CA2139421A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
| 01/19/1994 | EP0579412A1 1,2,4-trioxygenated benzene derivatives useful as a leukotriene antagonists |
| 01/19/1994 | EP0579304A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/19/1994 | EP0579196A1 Glycolipid derivatives |
| 01/19/1994 | EP0579155A2 Aqueous preparation of arulene sodium sulfonate |
| 01/19/1994 | EP0579066A2 N-substituted anilines |